• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday

    9/29/23 10:58:08 AM ET
    $ALLO
    $BMI
    $CORT
    $CRIS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Machinery/Components
    Industrials
    Get the next $ALLO alert in real time by email

    U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session.

    Corcept Therapeutics Incorporated (NASDAQ:CORT) shares fell 21% to $26.07.

    Lifezone Metals Limited (NYSE:LZM) shares tumbled 15.7% to $13.05.

    Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) fell 15% to $13.29. JP Morgan maintained Syndax Pharmaceuticals with an Overweight and lowered the price target from $36 to $33.

    Opera Limited (NASDAQ:OPRA) shares tumbled 11.3% to $11.57 after the company announced the pricing of its underwritten secondary public offering of 6,876,506 ADSs to be sold by a pre-IPO shareholder at a public offering price of $12.25 per ADS.

    Greenfire Resources Ltd. (NYSE:GFR) dipped 9.8% to $4.9605.

    LanzaTech Global, Inc. (NASDAQ:LNZA) fell 7.9% to $4.88. LanzaTech announced collaboration with Dow to introduce bio-degradable cleaning solution.

    Uranium Energy Corp. (NYSE:UEC) fell 7.7% to $5.16. Uranium Energy reported FY23 revenue of $163.95 million.

    Fathom Digital Manufacturing Corporation (NYSE:FATH) shares declined 7.7% to $5.54.

    Curis, Inc. (NASDAQ:CRIS) fell 7.6% to $7.02.

    Allogene Therapeutics, Inc. (NASDAQ:ALLO) declined 7.6% to $3.15.

    Badger Meter, Inc. (NYSE:BMI) shares declined 6.7% to $145.13. Northcoast Research downgraded Badger Meter from Neutral to Sell.

    Shengfeng Development Limited (NASDAQ:SFWL) fell 6.3% to $12.18.

    TG Therapeutics, Inc. (NASDAQ:TGTX) fell 5.5% to $8.28.

    Vail Resorts, Inc. (NYSE:MTN) fell 5.3% to $229.40 as the company posted weaker-than-expected sales for its fourth quarter. The company posted a quarterly loss of $3.35 per share, versus a year-ago loss of $2.70 per share.

    Carnival Corporation & plc (NYSE:CUK) fell 4.8% to $12.29 following third-quarter results.

    Now Read This: Sportsman's Warehouse And 3 Other Penny Stocks Insiders Are Buying

    Get the next $ALLO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLO
    $BMI
    $CORT
    $CRIS

    CompanyDatePrice TargetRatingAnalyst
    Badger Meter Inc.
    $BMI
    2/2/2026Buy → Hold
    Argus
    Vail Resorts Inc.
    $MTN
    1/13/2026$165.00Hold → Buy
    Jefferies
    Allogene Therapeutics Inc.
    $ALLO
    1/9/2026$5.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Badger Meter Inc.
    $BMI
    1/7/2026$157.00Underweight
    Barclays
    Corcept Therapeutics Incorporated
    $CORT
    12/31/2025$30.00Peer Perform → Underperform
    Wolfe Research
    Corcept Therapeutics Incorporated
    $CORT
    12/16/2025Neutral
    UBS
    Badger Meter Inc.
    $BMI
    12/12/2025$220.00Buy
    Jefferies
    Corcept Therapeutics Incorporated
    $CORT
    11/18/2025Peer Perform
    Wolfe Research
    More analyst ratings

    $ALLO
    $BMI
    $CORT
    $CRIS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Badger Meter downgraded by Argus

    Argus downgraded Badger Meter from Buy to Hold

    2/2/26 8:20:04 AM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    Vail Resorts upgraded by Jefferies with a new price target

    Jefferies upgraded Vail Resorts from Hold to Buy and set a new price target of $165.00

    1/13/26 8:44:26 AM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Allogene upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Allogene from Mkt Perform to Mkt Outperform and set a new price target of $5.00

    1/9/26 8:23:08 AM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALLO
    $BMI
    $CORT
    $CRIS
    SEC Filings

    View All

    Carnival Plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - CARNIVAL PLC (0001125259) (Filer)

    2/20/26 4:22:22 PM ET
    $CUK
    Marine Transportation
    Consumer Discretionary

    SEC Form 8-K filed by Corcept Therapeutics Incorporated

    8-K - CORCEPT THERAPEUTICS INC (0001088856) (Filer)

    2/19/26 4:38:20 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Curis Inc.

    DEF 14A - CURIS INC (0001108205) (Filer)

    2/19/26 4:12:37 PM ET
    $CRIS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALLO
    $BMI
    $CORT
    $CRIS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET to discuss results for the fourth quarter and full year 2025 and to provide a business outlook for 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com.

    2/23/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Syndax Announces Participation in March Investor Conferences

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences: TD Cowen 46th Annual Health Care Conference in Boston, MA, with a fireside chat on Monday, March 2, 2026, at 1:50 p.m. ET.Leerink Global Healthcare Conference in Miami Beach, FL, with a fireside chat on Wednesday, March 11, 2026, at 1:40 p.m. ET.Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, with a fireside chat on Thursday,

    2/23/26 7:00:00 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Princess Cruises Celebrates National Margarita Day by Breaking The GUINNESS WORLD RECORDS™ Title for Most Margaritas Sold in 8 Hours

    Princess Cruises also Marks the Sale of Over 1 Million Signature 24K Margaritas Made with Award-Winning Pantalones Organic TequilaCOZUMEL, Mexico, Feb. 22, 2026 /PRNewswire/ -- Princess Cruises raised a salted-rim glass to National Margarita Day in record-breaking style, breaking a new GUINNESS WORLD RECORDS™ title for the Most Margaritas Sold in 8 Hours. The celebration aboard Regal Princess sold 3,410 handcrafted 24K Margaritas featuring Pantalones Organic Blanco Tequila, surpassing the previously held record of 2,728. The record-setting event took place on February 17, while

    2/22/26 10:00:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    $ALLO
    $BMI
    $CORT
    $CRIS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLO
    $BMI
    $CORT
    $CRIS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Guardians Of New Zealand Superannuation bought $4,300,000 worth of shares (969,858 units at $4.43), increasing direct ownership by 292% to 1,302,492 units (SEC Form 4)

    4 - LanzaTech Global, Inc. (0001843724) (Issuer)

    2/18/26 8:17:53 PM ET
    $LNZA
    Major Chemicals
    Industrials

    Chairman, President & CEO Bockhorst Kenneth bought $502,986 worth of shares (3,300 units at $152.42), increasing direct ownership by 9% to 40,013 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/11/26 9:57:41 AM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    EVP-N.A. Muncipal Utility Wrocklage Robert bought $251,378 worth of shares (1,650 units at $152.35), increasing direct ownership by 9% to 19,541 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/10/26 9:38:13 AM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    $ALLO
    $BMI
    $CORT
    $CRIS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Guardians Of New Zealand Superannuation bought $4,300,000 worth of shares (969,858 units at $4.43), increasing direct ownership by 292% to 1,302,492 units (SEC Form 4)

    4 - LanzaTech Global, Inc. (0001843724) (Issuer)

    2/18/26 8:17:53 PM ET
    $LNZA
    Major Chemicals
    Industrials

    VP - Human Resources Hopkins Sheryl was granted 1,193 shares, increasing direct ownership by 26% to 5,850 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/17/26 6:00:12 PM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    VP-Cust Serv & GM SmartCover Stoll Kimberly K was granted 1,550 shares, increasing direct ownership by 38% to 5,038 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/17/26 6:00:13 PM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    $ALLO
    $BMI
    $CORT
    $CRIS
    Leadership Updates

    Live Leadership Updates

    View All

    Holland America Line Cruised Through the 99th Macy's Thanksgiving Day Parade® with Alaska-Themed Float Featuring Singer-Songwriter Jewel

    First-time float wows as glaciers, wildlife and scenery come to life with the largest kinetic sculpture in Parade history  SEATTLE, Nov. 27, 2025 /PRNewswire/ -- It was smooth sailing as Holland America Line's float cruised through the streets of New York this morning in the 99th Macy's Thanksgiving Day Parade®. The Alaska-themed showstopper featured multi-platinum singer-songwriter Jewel — an Alaska native — who performed her hit "You Were Meant For Me" during the television broadcast in front of iconic Macy's Herald Square flagship. Designed to bring the wonders of Alaska to

    11/27/25 2:18:00 PM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Vail Resorts Appoints Celeste Burgoyne as Chief Revenue Officer

    Seasoned business leader and lululemon executive joins the Company to help drive the next chapter of growth BROOMFIELD, Colo., Nov. 21, 2025 /PRNewswire/ -- Vail Resorts, Inc. (NYSE:MTN) today announced that Celeste Burgoyne, current President of the Americas and Global Guest Innovation for lululemon, has been appointed Executive Vice President & Chief Revenue Officer, effective January 26, 2026, to help drive the next chapter of growth for Vail Resorts. Burgoyne will oversee Vail Resorts' marketing function, lead all aspects of the guest journey and digital experience, and be directly responsible for the majority of the Company's revenue.

    11/21/25 8:30:00 AM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Holland America Line and RWS Global Partner to Bring the Legacy of Bob Fosse and Gwen Verdon to the International Stage for the First Time

    'Fosse and Verdon, The Duet That Changed Broadway' will debut in November, featuring never-before-seen archival footage NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Today, cruise line Holland America Line and RWS Global, the world's leader in live moments across entertainment and sports, announced the debut of "Fosse and Verdon, The Duet That Changed Broadway," an all-new live musical and multimedia tribute celebrating the revolutionary work of Bob Fosse and Gwen Verdon. Developed in collaboration with The Verdon Fosse Legacy®, the production marks the first international staging of their iconic work at sea.

    9/9/25 10:14:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    $ALLO
    $BMI
    $CORT
    $CRIS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Opera Limited

    SC 13D/A - Opera Ltd (0001737450) (Subject)

    12/6/24 6:15:42 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Greenfire Resources Ltd.

    SC 13D/A - Greenfire Resources Ltd. (0001966287) (Subject)

    11/21/24 9:11:27 PM ET
    $GFR
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13G/A filed by TG Therapeutics Inc.

    SC 13G/A - TG THERAPEUTICS, INC. (0001001316) (Subject)

    11/14/24 7:45:34 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLO
    $BMI
    $CORT
    $CRIS
    Financials

    Live finance-specific insights

    View All

    TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET to discuss results for the fourth quarter and full year 2025 and to provide a business outlook for 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com.

    2/23/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its fourth quarter and full year 2025 financial results and provide a business update on Thursday, February 26, 2026. In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, February 26, 2026. The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the

    2/19/26 7:00:00 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carnival Corporation & plc Announces Exchange Rate for Quarterly Dividend

    Dividend at an initial rate of $0.15 (U.S.) per share payable on February 27, 2026MIAMI, Feb. 18, 2026 /PRNewswire/ -- On December 19, 2025, Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK) announced a quarterly cash dividend of $0.15 (U.S.) per share. The dividend is payable on February 27, 2026, to shareholders of record on February 13, 2026. Holders of Carnival Corporation common stock or Carnival plc ADSs will receive the dividend payable in U.S. dollars. The dividend for Carnival plc ordinary shares will be payable in sterling unless shareholders elected to receive the dividend in U.S. dollars by February 13, 2026.Dividends payable in sterling will be converted from U.S. dollars at

    2/18/26 9:30:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary